VIVUS Inc. (VVUS)

4.04
NASDAQ : Health Technology
Prev Close 3.91
Day Low/High 3.76 / 4.10
52 Wk Low/High 2.15 / 5.78
Avg Volume 113.90K
Exchange NASDAQ
Shares Outstanding 10.64M
Market Cap 41.61M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Vivus (VVUS): Today's Featured Health Care Laggard

Vivus (VVUS): Today's Featured Health Care Laggard

Vivus was a leading decliner within the health care sector, falling $0.39 (-3.0%) to $12.48 on average volume

FMC = RISK: Vote The GOLD Proxy Card

FMC = RISK: Vote The GOLD Proxy Card

First Manhattan Outlines Strategic Plan To Fix VIVUS

First Manhattan Outlines Strategic Plan To Fix VIVUS

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

(Graphic: Business Wire)

(Graphic: Business Wire)

First Manhattan Co., the beneficial owner of approximately 9.

VIVUS Announces Study Results Showing STENDRA (Avanafil) Is Effective For Sexual Activity Within 15 Minutes In Men With Erectile Dysfunction (ED)

VIVUS Announces Study Results Showing STENDRA (Avanafil) Is Effective For Sexual Activity Within 15 Minutes In Men With Erectile Dysfunction (ED)

Data From Successful Placebo-Controlled Study to be Submitted to Regulatory Authorities to Support STENDRA Label Amendment for 15-Minute Efficacy Claim

VIVUS Posts Investor Presentation

VIVUS Posts Investor Presentation

Open Letter To Vivus Employees Released By First Manhattan Co.

Open Letter To Vivus Employees Released By First Manhattan Co.

First Manhattan Co., the beneficial owner of approximately 9.

Bullish Two Hundred Day Moving Average Cross - VVUS

Bullish Two Hundred Day Moving Average Cross - VVUS

In trading on Thursday, shares of Vivus, Inc. crossed above their 200 day moving average of $14.90, changing hands as high as $15.04 per share.

4 Stocks Spiking on Big Volume

4 Stocks Spiking on Big Volume

Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Happy Day for Arena Bulls, Bears as Belviq Launch Finally Arrives

Happy Day for Arena Bulls, Bears as Belviq Launch Finally Arrives

DEA finalizes Belviq abuse schedule, allowing the weight-loss pill launch in June.

TheStreet Quant Rating: D (Sell)